Recurrent Lower Urinary Tract Infections Have a Detrimental Effect on Patient Quality of Life: a Prospective, Observational Study

Infectious Diseases and Therapy

Volumn 4, Issue 1, 2015, Pages 125-135

  Renard, Julien ^a   Ballarini, Stefania ^b   Mascarenhas, Teresa ^c   Zahran, Mohamed ^d   Quimper, Enrique ^e   Choucair, Jacques ^f   Iselin, Christophe E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Vifor (International) Inc   (Switzerland)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

^d CAIRO UNIVERSITY   (Egypt)

^e UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^f SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Cystitis; Prophylaxis; Quality of life; Urinary tract infection

Indexed keywords

OM 89;

ADULT; ANXIETY; ARTICLE; ASSESSMENT OF HUMANS; ASTHENIA; CHEMOPROPHYLAXIS; CYSTITIS; DAILY LIFE ACTIVITY; DEPRESSION; DYSURIA; EMOTION ASSESSMENT; ESCHERICHIA COLI; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LEICESTER SCORE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; POLLAKISURIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84977098461     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-014-0054-6     Document Type: Article

References (30)

1. Grabe M, Bjerklund-Johansen TE, Botto H, et al. European Association of Urology guidelines on urological infections. 2010. http://www.uroweb.org. Accessed April 1, 2010.
2. McCue JD. UTIs in at-risk patients: are they ‘complicated’? Infect Med. 1999;16:533–40.
3. Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17:227–41.
4. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113:5S–13S.
5. Guay DR. Contemporary management of uncomplicated urinary tract infections. Drugs. 2008;68:1169–205.
6. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103–20.
7. Grabe M, Bjerklund-Johansen TE, Botto H, et al. European Association of Urology guidelines on urological infections 2014 (limited update of 2013). http://www.uroweb.org. Accessed April 1, 2014.
8. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69:4572–9.
9. Epp A, Larochelle A, Lovatsis D, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can. 2010;32:1082–101.
10. Chiavaroli C, Moore A. An hypothesis to link the opposing immunological effects induced by bacterial lysate OM-89 in urinary tract infection and rheumatoid arthritis. Biodrugs. 2006;20:141–9.
11. Schulman CC, Corbusier A, Michiels H, Taenzer HJ. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol. 1993;150:917–21.
12. Magasi P, Panovics J, Illes A, Nagy M. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol. 1994;26:137–40.
13. Bauer HW, Alloussi S, Egger G, Blümlein HM, Cozma G, Schulman CC. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol. 2005;47:542–8.
14. Bauer HW, Rahlfs VW, Lauener PA, Blessmann GS. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents. 2002;19:451–6.
15. Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009;33:111–9.
16. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003;79:428–32.
17. Lowe NK, Ryan-Wenger NA. Military women’s risk factors for and symptoms of genitourinary infections during deployment. Mil Med. 2003;168:569–74.
18. Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract. 2000;13:392–7.
19. De Moura JL. Urinary infection in the adult. Acta Med Port. 1999;12:57–62.
20. Schleupner CJ. Urinary tract infections. Postgrad Med. 1997;101:231–7.
21. Bula CJ, Ghilardi G, Wietlisbach V, Petignat C, Francioli P. Infections and functional impairment in nursing home residents: a reciprocal relationship. J Am Geriatr Soc. 2004;52:700–6.
22. Van Oyen H, Van Oyen P. Urinary incontinence in Belgium; prevalence, correlates and psychosocial consequences. Acta Clin Belg. 2002;57:207–18.
23. Gonder MJ. Urologic considerations in the elderly. Prim Care. 1982;9:71–5.
24. Woo BK, Daly JW, Allen EC, Jeste DV, Sewell DD. Unrecognized medical disorders in older psychiatric inpatients in a senior behavioral health unit in a university hospital. J Geriatr Psychiatry Neurol. 2003;16:121–5.
25. Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women’s quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes. 2005;3:45.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
27. Shaw C, Matthews RJ, Perry SI, et al. Validity and reliability of a questionnaire to measure the impact of lower urinary tract symptoms on quality of life: the Leicester Impact Scale. Neurourol Urodyn. 2004;23:229–36.
28. Carr AJ, Gibson B, Robinson PG. Measuring quality of life: Is quality of life determined by expectations or experience? BMJ. 2001;322:1240–3.
29. Platt FW, Keating KN. Differences in physician and patient perceptions of uncomplicated UTI symptom severity: understanding the communication gap. Int J Clin Pract. 2007;61:303–8.
30. Bermingham SL, Ashe JF. Systematic review of the impact of urinary tract infections on health-related quality of life. BJU Int. 2012;110:E830–6.